Drug Price Trends for VANCOMYCIN HCL

Average Pharmacy Cost for VANCOMYCIN HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
VANCOMYCIN HCL 125 MG CAPSULE	00121-0867-20	1.16331	EACH	2024-12-18
VANCOMYCIN HCL 125 MG CAPSULE	00121-0867-50	1.16331	EACH	2024-12-18
VANCOMYCIN HCL 125 MG CAPSULE	23155-0858-78	1.16331	EACH	2024-12-18
VANCOMYCIN HCL 125 MG CAPSULE	23155-0858-25	1.16331	EACH	2024-12-18

Best Wholesale Price for VANCOMYCIN HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Unit	Dates	Price Type
VANCOMYCIN HCL 1.25GM/VIL INJ	Mylan Institutional LLC	67457-0823-99	1x10	142.54			2023-09-29 - 2028-09-28	Big4
VANCOMYCIN HCL 750MG/VIL INJ	Mylan Institutional LLC	67457-0705-75	10	45.67	4.56700	EACH	2023-09-29 - 2028-09-28	Big4
VANCOMYCIN HCL 1.5GM/VIL INJ	Mylan Institutional LLC	67457-0824-99	1x10	141.07			2023-10-12 - 2028-09-28	FSS
VANCOMYCIN HCL 1.25GM/VIL INJ	Mylan Institutional LLC	67457-0823-99	1x10	142.54			2023-09-29 - 2028-09-28	FSS

Vancomycin HCL Market Analysis and Price Projections

Market Overview

The global vancomycin market is experiencing significant growth, driven by several key factors. Here are the main points to consider:

Market Size and Growth

The global vancomycin market was estimated at USD 396.7 million in 2023 and is projected to reach USD 555.5 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.9% from 2023 to 2030[1].

Driving Factors

• Increasing Prevalence of Antibiotic-Resistant Infections: The rise in antibiotic-resistant infections, particularly MRSA (Methicillin-resistant Staphylococcus aureus), has increased the demand for vancomycin as a last-line treatment option[1].
• Advancements in Manufacturing: Improved production techniques have led to higher yields, enhanced purity, and reduced production costs, making vancomycin more accessible[1].
• Rising Awareness of Infection Control: Enhanced infection control practices in healthcare settings have further boosted the demand for vancomycin[1].

Regional Analysis

• U.S. Market: Estimated at $103.9 million in 2023, the U.S. market is a significant segment of the global vancomycin market[1].
• China: Forecasted to grow at an impressive 8.2% CAGR to reach $130.4 million by 2030, China is another key region driving market growth[1].
• Other Regions: Japan, Canada, Germany, and the Asia-Pacific region are also experiencing growth trends in the vancomycin market[1].

Application Segments

• Lung Infections: Expected to reach USD 201.9 million by 2030 with a CAGR of 6.1%[1].
• Sepsis: Set to grow at a 5.1% CAGR over the analysis period[1].
• Endocarditis and Meningitis: Increasing adoption of vancomycin in treating these conditions is driving demand[1].
• Skin and Soft Tissue Infections: The treatment of severe skin and soft tissue infections is another expanding application of vancomycin[1].

Competitive Landscape

Major players in the global vancomycin market include Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, CJ CheilJedang, and others. These companies are driving innovation and competition in the market[1].

Price Trends

Recent Price Decline

As of May 2023, Vancomycin Hydrochloride prices in the U.S. have declined about 10% from their January 2023 peak. This decline is attributed to weaker domestic demand, increased supply, and the approval of new generic versions by the FDA in 2022[2].

Factors Influencing Prices

• Supply Increase: Increased production by existing manufacturers and the approval of new generic versions have pressured prices downward[2].
• Geopolitical Tensions: Ongoing trade tensions, particularly between the U.S. and China, have disrupted global supply chains and affected prices[2].
• Inventory Clearance: Manufacturers and suppliers have reduced prices to clear inventory, further impacting market prices[2].

Future Price Projections

Despite the current decline, a moderate increase in the price of Vancomycin Hydrochloride is expected in the upcoming months as market players replenish their inventories with fresh stock[2].

Product Pricing

Here are some current price ranges for different formulations of vancomycin:

• Vancomycin Intravenous Powder for Injection:

  • 2 g: $446.08 for 10 units ($44.61 per unit)[5]
  • 5 g: $26.26 - $30.23 per unit[5]

• Vancomycin Intravenous Solution:

  • 1 g/200 mL-NaCl 0.9%: $155.10 for 1200 milliliters ($0.13 per unit)[5]
  • 5%-1 g/200 mL: $175.18 for 1200 milliliters ($0.15 per unit)[5]
  • 1.25 g/250 mL: $125.78 for 1500 milliliters ($0.08 per unit)[5]
  • 1.25 g/250 mL-D5%: $57.52 for 250 milliliters ($0.23 per unit)[5]

Key Takeaways

• The global vancomycin market is expected to grow significantly due to the increasing prevalence of antibiotic-resistant infections and advancements in manufacturing.
• Regional markets, particularly the U.S. and China, are driving this growth.
• Various application segments, including lung infections and sepsis, are contributing to the market expansion.
• Current prices have declined due to increased supply and weaker demand, but a moderate price increase is anticipated in the future.
• Major players are innovating and competing in the market, influencing price trends and market dynamics.

FAQs

What is the projected market size of the global vancomycin market by 2030?

The global vancomycin market is projected to reach USD 555.5 million by 2030[1].

What are the main drivers of the vancomycin market growth?

The main drivers include the increasing prevalence of antibiotic-resistant infections, advancements in manufacturing processes, and rising awareness of infection control measures[1].

Which regions are expected to see significant growth in the vancomycin market?

The U.S. and China are expected to see significant growth, with China forecasted to grow at an 8.2% CAGR by 2030[1].

Why have Vancomycin Hydrochloride prices declined recently?

Prices have declined due to weaker domestic demand, increased supply, and the approval of new generic versions by the FDA in 2022[2].

What is the expected future trend in Vancomycin Hydrochloride prices?

A moderate increase in prices is expected in the upcoming months as market players replenish their inventories with fresh stock[2].

Sources

1. Globenewswire: Vancomycin Markets - Global Strategic Business Report Q4, 2024.
2. ChemAnalyst: US Vancomycin Hydrochloride Prices Witness Downtrend Amid Declining Demand.
3. MarketResearchIntellect: Global Vancomycin Hydrochloride For Injection Market Size, Scope.
4. BusinessResearchInsights: Vancomycin Market Size, Global Share & Forecast [2032].
5. Drugs.com: Vancomycin Prices, Coupons, Copay Cards & Patient Assistance.